Literature DB >> 7679893

The hepatic acute-phase proteins alpha 1-antitrypsin and alpha 2-macroglobulin inhibit binding of transferrin to its receptor.

I Graziadei1, R Kaserbacher, H Braunsteiner, W Vogel.   

Abstract

Transferrin binding to human placental sites was inhibited by the acute-phase proteins alpha 1-antitrypsin (alpha 1-AT) and alpha 2-macroglobulin (alpha 2-MG), whereas haptoglobin, C-reactive protein and ferritin displayed no such effect. In equilibrium saturation binding assays, the effective acute-phase proteins decreased the apparent affinity of the binding sites for transferrin, but the transferrin binding-site density Bmax. was not significantly changed. For instance, the addition of 30 microM alpha 1-AT increased the KD of transferrin from 8.46 +/- 1.51 nM to 21.6 +/- 3.04 nM; the Bmax. values were 1.17 +/- 0.18 pmol/mg of protein and 1.04 +/- 0.25 pmol/mg of protein respectively. In kinetic studies, alpha 1-AT decreased the association rate constant k+1 of the 125I-transferrin-binding-site complex from 2.18(+/- 0.21) x 10(7) M-1.min-1 to 3.99(+/- 0.18) x 10(6) M-1.min-1. In contrast, the dissociation rate constant k-1 was not changed (0.0948 +/- 0.002 min-1, 0.089 +/- 0.0017 min-1). On isoelectric focusing, no alteration in transferrin protein pattern or shift in isoelectric point was detected in the presence of alpha 1-AT. Inhibition of transferrin binding by the acute-phase proteins alpha 1-AT and alpha 2-MG is competitive. Interestingly, inhibition is already present at physiological concentrations. However, full inhibition is only achieved at concentrations above the normal range, which are attained in acute-phase reactions.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7679893      PMCID: PMC1132388          DOI: 10.1042/bj2900109

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  31 in total

1.  The plasma-to-cell cycle of transferrin.

Authors:  J H JANDL; J H KATZ
Journal:  J Clin Invest       Date:  1963-03       Impact factor: 14.808

2.  The metabolism of alpha2-macroglobulin in mildly burned patients.

Authors:  S P Farrow; S Baar
Journal:  Clin Chim Acta       Date:  1973-06-14       Impact factor: 3.786

3.  Transferrin receptors: structure and function.

Authors:  I S Trowbridge; R A Newman; D L Domingo; C Sauvage
Journal:  Biochem Pharmacol       Date:  1984-03-15       Impact factor: 5.858

4.  Studies of the transferrin receptor on both human reticulocytes and nucleated human cells in culture: comparison of factors regulating receptor density.

Authors:  J L Frazier; J H Caskey; M Yoffe; P A Seligman
Journal:  J Clin Invest       Date:  1982-04       Impact factor: 14.808

Review 5.  Structure and variation of human alpha 1-antitrypsin.

Authors:  R W Carrell; J O Jeppsson; C B Laurell; S O Brennan; M C Owen; L Vaughan; D R Boswell
Journal:  Nature       Date:  1982-07-22       Impact factor: 49.962

6.  Binding of C-reactive protein to chromatin and nucleosome core particles. A possible physiological role of C-reactive protein.

Authors:  F A Robey; K D Jones; T Tanaka; T Y Liu
Journal:  J Biol Chem       Date:  1984-06-10       Impact factor: 5.157

7.  The complete amino acid sequence of human serum transferrin.

Authors:  R T MacGillivray; E Mendez; S K Sinha; M R Sutton; J Lineback-Zins; K Brew
Journal:  Proc Natl Acad Sci U S A       Date:  1982-04       Impact factor: 11.205

8.  The effect of alpha 1 antitrypsin on phagocyte function.

Authors:  S N Breit; J P Robinson; R Penny
Journal:  J Clin Lab Immunol       Date:  1983-03

Review 9.  Iron metabolism in reticuloendothelial cells.

Authors:  A Deiss
Journal:  Semin Hematol       Date:  1983-04       Impact factor: 3.851

10.  Examination of different preparations of human placental plasma membrane for the binding of insulin, transferrin and immunoglobulins.

Authors:  M Davies; J E Parry; R G Sutcliffe
Journal:  J Reprod Fertil       Date:  1981-11
View more
  7 in total

1.  Divergent effects of alpha 1-antitrypsin on the regulation of iron metabolism in human erythroleukaemic (K562) and myelomonocytic (THP-1) cells.

Authors:  G Weiss; I Graziadel; M Urbanek; K Grünewald; W Vogel
Journal:  Biochem J       Date:  1996-11-01       Impact factor: 3.857

Review 2.  Interaction of inflammatory cytokines and erythropoeitin in iron metabolism and erythropoiesis in anaemia of chronic disease.

Authors:  M Jongen-Lavrencic; H R Peeters; G Vreugdenhil; A J Swaak
Journal:  Clin Rheumatol       Date:  1995-09       Impact factor: 2.980

3.  Exploring transferrin-receptor interactions at the single-molecule level.

Authors:  Alexandre Yersin; Toshiya Osada; Atsushi Ikai
Journal:  Biophys J       Date:  2007-09-14       Impact factor: 4.033

4.  Whole-body iron transport and metabolism: Mechanistic, multi-scale model to improve treatment of anemia in chronic kidney disease.

Authors:  Joydeep Sarkar; Alka A Potdar; Gerald M Saidel
Journal:  PLoS Comput Biol       Date:  2018-04-16       Impact factor: 4.475

5.  Deficiency of α-1-antitrypsin influences systemic iron homeostasis.

Authors:  Andrew J Ghio; Joleen M Soukup; Judy H Richards; Bernard M Fischer; Judith A Voynow; Donald E Schmechel
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2013-01-22

Review 6.  The impact of alpha-1 antitrypsin augmentation therapy on neutrophil-driven respiratory disease in deficient individuals.

Authors:  Danielle M Dunlea; Laura T Fee; Thomas McEnery; Noel G McElvaney; Emer P Reeves
Journal:  J Inflamm Res       Date:  2018-03-26

7.  Association of Fecal Markers of Environmental Enteric Dysfunction with Zinc and Iron Status among Children at First Two Years of Life in Bangladesh.

Authors:  Shah Mohammad Fahim; Subhasish Das; Kazi Istiaque Sanin; Md Amran Gazi; Mustafa Mahfuz; M Munirul Islam; Tahmeed Ahmed
Journal:  Am J Trop Med Hyg       Date:  2018-06-07       Impact factor: 2.345

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.